Related Experiment Video
Updated: Jun 3, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Significance of mitral valve repair for active-phase infective endocarditis
Tadashi Omoto1, Takeo Tedoriya, Masaya Oi
1Department of Surgery, Division of Thoracic and Cardiovascular Surgery, Showa University, Hatanodai 1-5-8, Shinagawa-ku, Tokyo, Japan. tomoto@med.showa-u.ac.jp
Abstract:
Mitral valve repair is preferred to replacement in infective endocarditis, but in the active phase, it often requires extensive debridement of infected tissue and complex reconstruction. We investigated 22 consecutive native mitral valve operations during active-phase infective endocarditis. The time from initiation of medical treatment to operation was 16.8 ± 16.4 days. Mitral valve repair was performed in 15 (68.2%) patients, using prosthetic annuloplasty in 14, an autologous pericardial patch in 11, and artificial chordal replacement in 9. Hospital mortality was 9.1% (2 patients), due to subarachnoid hemorrhage and pneumonia. One patient died 26 months after valve replacement due to congestive heart failure. The postoperative left ventricular end-diastolic dimension was significantly smaller (45.7 ± 5.6 vs. 53.3 ± 10.2 mm) and ejection fraction was significantly higher (57.0% ± 14.7% vs. 40.1% ± 8.2%) in patients who underwent valve repair compared to those who had valve replacement. Mitral regurgitation requiring reoperation occurred in 3 patients during follow-up. Mitral valve repair is feasible in active-phase infective endocarditis, and results in improved regression of left ventricular dimensions compared to valve replacement. However, complex mitral valve repair with extensive leaflet resection may not have long-term durability.
Insights
Mitral valve repair is feasible during active infective endocarditis, offering better left ventricular function post-surgery. However, complex repairs may lack long-term durability.
Area of Science:
- Cardiovascular Surgery
- Infectious Diseases
- Cardiac Pathology
Background:
- Mitral valve repair is generally preferred over replacement in infective endocarditis.
- Active-phase endocarditis necessitates extensive debridement and complex reconstruction for mitral valve repair.
Purpose of the Study:
- To investigate the feasibility and outcomes of mitral valve repair during the active phase of infective endocarditis.
- To compare the postoperative left ventricular dimensions and function between mitral valve repair and replacement in active infective endocarditis.
Main Methods:
- Retrospective analysis of 22 consecutive native mitral valve operations during active-phase infective endocarditis.
- Mitral valve repair techniques included prosthetic annuloplasty, autologous pericardial patch, and artificial chordal replacement.
- Comparison of postoperative left ventricular end-diastolic dimension and ejection fraction between repair and replacement groups.
Main Results:
- Mitral valve repair was performed in 15 patients (68.2%).
- Hospital mortality was 9.1%.
- Valve repair patients showed significantly smaller left ventricular end-diastolic dimensions and higher ejection fractions postoperatively compared to valve replacement patients. Three patients required reoperation for mitral regurgitation.
Conclusions:
- Mitral valve repair is a feasible option in active infective endocarditis, leading to improved left ventricular remodeling.
- Complex mitral valve repair strategies, particularly those involving extensive leaflet resection, may compromise long-term durability.
Related Concept Videos
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Mitral Stenosis I: Introduction
Endocarditis IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
